Literature DB >> 4075587

Delayed type hypersensitivity (DTH) skin reaction to hepatitis B surface antigen (HBsAg) in patients with type B acute and chronic hepatitis.

S Nagafuchi, S Kashiwagi, S Hayashi, T Inoue, S Imayama, M Takeshita, M Kikuchi.   

Abstract

Skin reactivity to HBsAg was studied in patients with type B acute and chronic hepatitis and in healthy controls. HBsAg preparations containing 50 micrograms/ml of antigen both with and without alum elicited positive skin reactions in all seven anti-HBs+ persons. Histological examination of skin tissue from the reactive area using monoclonal antibodies to the cell surface of lymphocytes revealed accumulation of Leu-3a positive lymphocytes, showing that the inflammation was a typical delayed type hypersensitivity (DTH) reaction. Irrespective of the presence of HBeAg and anti-HBe, patients with chronic type B hepatitis responded clearly to PPD and SK/SD antigens, whereas they did not exhibit DTH skin reactivity to HBsAg. In contrast, although patients with acute type B hepatitis did not exhibit specific DTH a reaction to HBsAg in the acute period, they began to develop DTH skin reactivity to HBsAg in the convalescent phase of the disease preceding the appearance of anti-HBs antibody. It is suggested that DTH reaction to HBsAg might play an important role in the pathogenesis of type B viral hepatitis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4075587      PMCID: PMC1577265     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  Lack of leukocyte migration inhibition by hepatitis B antigen and normal nonspecific immunoreactivity in asymptomatic carriers.

Authors:  M Desaules; P C Frei; J Libanska; B Wuilleret
Journal:  J Infect Dis       Date:  1976-11       Impact factor: 5.226

2.  New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants.

Authors:  L O Magnius; J A Espmark
Journal:  J Immunol       Date:  1972-11       Impact factor: 5.422

3.  A re-evaluation of the skin test of herpes simplex virus.

Authors:  Y Yamamoto
Journal:  Jpn J Microbiol       Date:  1966-04

4.  Studies on delayed hypersensitivity to hepatitis B antigen in chimpanzees.

Authors:  A B Ibrahim; G N Vyas; A M Prince
Journal:  Clin Exp Immunol       Date:  1974-06       Impact factor: 4.330

5.  Lymphocyte transformation and leucocyte migration-inhibition by Australia antigen.

Authors:  A A Laiwah; A K Chaudhuri; J R Anderson
Journal:  Clin Exp Immunol       Date:  1973-09       Impact factor: 4.330

Review 6.  Clinical pathologic correlation in viral hepatitis. The effect of the virus on the liver.

Authors:  H Popper
Journal:  Am J Pathol       Date:  1975-12       Impact factor: 4.307

7.  Development of DTH skin reaction to HBsAg in individuals immunized with HB vaccine.

Authors:  S Kashiwagi; S Nagafuchi; T Inoue; S Hayashi; S Takeshita; S Imayama
Journal:  Microbiol Immunol       Date:  1984       Impact factor: 1.955

8.  Cell-mediated immune reactivity to hepatitis B surface antigen in liver diseases.

Authors:  M C de Moura; S J Vernace; F Paronetto
Journal:  Gastroenterology       Date:  1975-08       Impact factor: 22.682

9.  Lymphocyte stimulation in hepatitis B infections.

Authors:  M J Tong; A M Wallace; R L Peters; T B Reynolds
Journal:  N Engl J Med       Date:  1975-08-14       Impact factor: 91.245

10.  Cell-mediated immunity in patients positive for hepatitis-associated antigen.

Authors:  F J Dudley; V Giustino; S Sherlock
Journal:  Br Med J       Date:  1972-12-30
View more
  2 in total

1.  Cell-mediated immunity to hepatitis B virus antigens in mice: correlation of in vivo and in vitro assays.

Authors:  P A De Moerloose; I H Frazer; W A Sewell; E J Collins; I R Mackay
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330

2.  Immune response to hepatitis B virus surface antigen peptides during HBV infection.

Authors:  A Mishra; H Durgapal; V Manivel; S K Acharya; K V Rao; S K Panda
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.